Copyright
©The Author(s) 2017.
World J Cardiol. Sep 26, 2017; 9(9): 715-722
Published online Sep 26, 2017. doi: 10.4330/wjc.v9.i9.715
Published online Sep 26, 2017. doi: 10.4330/wjc.v9.i9.715
Table 1 Summary of the characteristics of carbon dioxide and against iodinated contrast agents
| Characteristics | Carbon dioxide | Iodinated contrast agents |
| Overall sensitivity | Less | Higher |
| Overall specificity | Less | Higher |
| Nephrotoxicity | No | Yes |
| Allergenic | No | Yes |
| Cost | Low | High |
| Ease of administration | Cumbersome | Easier |
| Limitations | Visibility and air contamination | Dose related toxicity and allergy |
| Delivery via small caliber catheters | Possible | Difficult |
| Radiation exposure | Increased if digital subtraction angiography used | Standard |
| Dose | Rate related toxicity | Volume related nephrotoxicity |
| Contraindications | Pulmonary-systemic communications; not for use in heart, brain or spinal vasculature | Allergy, nephrotoxicity |
| Hepatotoxicity | Rare | Rare |
| Quality of image | Good | Better |
| Procedure duration | Increased | Standard |
- Citation: Ali F, Mangi MA, Rehman H, Kaluski E. Use of carbon dioxide as an intravascular contrast agent: A review of current literature. World J Cardiol 2017; 9(9): 715-722
- URL: https://www.wjgnet.com/1949-8462/full/v9/i9/715.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i9.715
